Q3’s biggest healthcare deals: mRNA, digital care and cybersecurity

Here are the 10 biggest healthcare deals in 2021’s third quarter:

1. Chinese mRNA drugmaker Abogen raised $700 million in a series C funding round.
2. Cambridge, Mass.-based mRNA drugmaker Laronde raised $440 million in a series B funding round.
3. Columbus, Ohio-based healthcare automation company Olive raised $400 million in a series H funding round.
4. Chinese artificial intelligence drug discovery company XtalPi raised $400 million in a series D funding round.
5. Charlotte, N.C.-based care platform Cityblock Health raised $400 million in a series D funding round.
6. San Francisco-based digital healthcare provider Carbon Health raised $350 million in a series D funding round.
7. Chinese online insurance firm Zhiyuan Zhongan raised $309 million.
8. Chinese healthcare payment and digital care platform MediTrust Health raised $308 million in a series C funding round.
9. Santa Clara, Calif.-based cloud security provider Netskope raised $300 million in a series H funding round.
10. Boston-based cyber defense platform developer Cybereason raised $275 million in a series F funding round.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.